SCHEMBL233841

SCHEMBL233841

CCC(=[N+]=[N-])C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9392848 0.84 FFAR3 (0.36)
O-Xylene SCHEMBL21612746 0.82 ERCC5 (0.40)
SCHEMBL5898027 0.72 LDHA (0.42)
SCHEMBL25369487 0.72 GPR84 (0.52)
SCHEMBL22778115 0.72 GPR84 (0.52)
SCHEMBL8801998 0.72 GPR84 (0.52)
SCHEMBL23113779 0.72 CES2 (0.50)
Acetic Acid SCHEMBL27430540 0.72 FFAR3 (0.33)
SCHEMBL8913069 0.72
SCHEMBL7385758 0.70 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 584 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP claimed
US-20180250277-A1 POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR H. LUNDBECK A/S (DK) 2018-09-06 US claimed
EP-2370377-B1 PROCESS FOR THE PRODUCTION OF CYCLOPROPANE DERIVATIVES DSM FINE CHEM AUSTRIA GMBH (AT) 2015-09-16 EP claimed
US-8497384-B2 Process for the production of cyclopropane derivatives DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2013-07-30 US claimed
US-20110301359-A1 PROCESS FOR THE PRODUCTION OF CYCLOPROPANE DERIVATIVES PATHEON AUSTRIA GMBH & CO KG (AT) 2011-12-08 US claimed
EP-2370377-A1 PROCESS FOR THE PRODUCTION OF CYCLOPROPANE DERIVATIVES DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) 2011-10-05 EP claimed
EP-1848695-B1 COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE GLAXO GROUP LTD (GB) 2011-07-27 EP claimed
WO-2010055106-A1 PROCESS FOR THE PRODUCTION OF CYCLOPROPANE DERIVATIVES DSM FINE CHEMICALS AUSTRIA NFG. GMBH & CO KG (AT) 2010-05-20 WO claimed
WO-2005051890-A1 AMINOPHENYLCYCLOPROPYL CARBOXYLIC ACIDS AND DERIVATIVES AS AGONISTS TO GPR40 SMITHKLINE BEECHAM CORPORATION (US) 2005-06-09 WO claimed
EP-0923540-B1 SYNTHESIS OF A HYDRAZONE BETA-KETO ESTER BY THE REACTION WITH A DIAZO ESTER MONSANTO TECHNOLOGY LLC (US) 2002-03-27 EP claimed
EP-0594608-B1 CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS RES CORP TECHNOLOGIES INC (US) 1997-10-15 EP claimed
EP-0363994-B1 (2R,3S,4S)-ALPHA-(CARBOXYCYCLOPROPYL)GLYCINE SUNTORY LIMITED (JP) 1993-09-22 EP claimed
US-20260092053-A1 KHK INHIBITORS GILEAD SCIENCES INC (US) 2026-04-02 US disclosed
EP-4709729-A1 PYRAZOLO[4,3-F]QUINAZOLINE DERIVATIVES AS MODULATORS OF G12D MUTANT KRAS USEFUL FOR THE TREATMENT OF CANCER Jazz Pharmaceuticals Ireland Ltd. (IE) 2026-03-18 EP disclosed
EP-4681774-A2 KHK INHIBITORS Gilead Sciences, Inc. (US) 2026-01-21 EP disclosed
EP-4313967-B1 KHK INHIBITORS GILEAD SCIENCES INC (US) 2025-11-12 EP disclosed
US-4081550-A KETOALKANESULFENYL AND KETOALKANETHIOSULFENYL CARBAMATES UNION CARBIDE CORPORATION (US) 1978-03-28 US disclosed
US-4066689-A KETOALKANESULFENYLCARBAMOYL AND KETOALKANETHIOSULFENYLCARBAMOYL HALIDES UNION CARBIDE CORPORATION (US) 1978-01-03 US disclosed
US-4016204-A ISOMERIZING ETHYL-2-PHENYL-CYCLOPROPANE CARBOXYLATE NELSON RESEARCH & DEVELOPMENT COMPANY (US) 1977-04-05 US disclosed
US-3940407-A β-Adrenergic blocking agents in the 1,2,3-thiadiazole series SYNTEX (U.S.A.) INC. (US) 1976-02-24 US disclosed